A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...

Caremark, the pharmacy benefit manager owned by CVS Health (NYSE:CVS), is reportedly trying to get Novo Nordisk (NVO) to agree to cover a month's supply of its blockbuster GLP-1 weight loss treatment ...

CVS is set to drop Zepbound as a medicine, but will continue to carry other popular weight loss drugs instead. Russia issues nuclear warning after Trump's weapons for Ukraine plan Anna Camp Airs ...

Rising prescription drug costs remain a top healthcare concern, with pharmacy benefit managers (PBMs) facing heightened scrutiny for their role in managing prescription drug benefits for insurers and ...

More people are paying out-of-pocket for GLP-1 weight loss drugs — and more retailers are offering discounts on Zepbound, Ozempic, and Wegovy. Walmart will offer in-store pickup for Zepbound at ...